£11.6M
LabGenius raises £11.6m in a Series A extension led by Atomico to scale its drug discovery platform.
The funding round was led by Atomico with participation from Lux Capital, Obvious Ventures, Kindred Capital and Inovia Capital.
L
LabGenius
LabGenius discovers next-generation protein therapeutics using machine learning and automation.
London, UK—Founded 2012
£11.6MTotal raised
LabGenius develops machine learning-driven protein engineering platforms to discover next-generation therapeutics. The London-based company uses robotic automation and synthetic biology to improve drug discovery.
Filed accounts
Cash at bank
Members only
Net current assets
Members only
Total assets less current liabilities
Members only
Net assets
Members only
Shareholders' funds
Members only
Current assets
Members only
Cash, assets and headcount from LabGenius's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Founders
James Field
Founder and CEO